NEW YORK, NY / ACCESS Newswire / December 24, 2025 / In early-stage companies, partnerships are often treated as marketing events. Logos get added to slides. Press releases get circulated. Little ...

Oracle (ORCL) stock slid in Thursday premarket trading, as investors were disappointed by the cloud software giant's current quarter guidance and increased spending forecast for 2026. In light of ...

SailPoint Technologies Holdings Inc. (NYSE:SAIL) reached a significant milestone in its Q3 2026 results, surpassing $1 billion in annual recurring revenue (ARR) while demonstrating strong momentum in ...

Annual Recurring Revenue (ARR): Surpassed $1 billion, reaching $1.04 billion, a 28% year-over-year increase. SaaS ARR: Grew 38% year-over-year to $669 million, representing 64% of total ARR. Revenue: ...

Bitcoin (BTC-USD) furthers recent losses, with the cryptocurrency on track for its worst monthly performance since 2022. Yahoo Finance Senior Markets Reporter Ines Ferré explains that one factor ...

INDICATION YET OF WHEN THAT SECTION OF ROAD MIGHT REOPEN.. FOR 17 MONTHS THE REGENTS SLIDE SOUTH OF BIG SUR HAS BLOCKED TRAVEL FROM NORTHERN TO SOUTHERN CALIFORNIA VIA HIGHWAY ONE.. ON THURSDAY THE ...

(TNS) — The data systems states use to track students' progress over time from pre-K to career have taken on new importance as educators and lawmakers try to keep up with rapidly shifting workforce ...

NEW DELHI: The National Capital Region Transport Corporation (NCRTC) has launched its innovative ‘Solar on Track’ project at the Namo Bharat Depot in Duhai — the first such initiative in any Rapid ...

The Power Systems segment emerged as the standout performer with an 18% revenue increase to $2.00 billion, driven primarily by increased power generation demand, particularly for data center ...

The hurricane is expected to clear Bermuda in the open Atlantic, but where the new systems could threaten remains in question. Hurricane Gabrielle rapidly intensified into a Category 4 storm Monday as ...

Teva Pharmaceuticals (NYSE:TEVA) said that the U.S. FDA has granted fast track designation to its experimental therapy TEV-56286 (emrusolmin) for treating Multiple System Atrophy. Emrusolmin, ...